We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current PHVS market cap is 858.08M. The company's latest EPS is EUR -1.9291 and P/E is -8.51.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -26.2M | -27.18M | -28.31M | -40.84M | -37.9M |
| Net Income | -23.6M | -32.75M | -28.02M | -29.73M | -41.71M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.01M | -25.01M | -54.14M | -86.71M | -96.91M |
| Net Income | -8.03M | -25.99M | -42.73M | -76.33M | -100.88M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 169.34M | 398.69M | 377.6M | 351.85M | 313.18M |
| Total Liabilities | 16.21M | 14.65M | 18.43M | 19.08M | 16.39M |
| Total Equity | 153.13M | 384.05M | 359.17M | 332.77M | 296.79M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 20.6M | 101.1M | 212.09M | 167.73M | 398.69M |
| Total Liabilities | 1.92M | 5.31M | 7.14M | 18.47M | 14.65M |
| Total Equity | 18.67M | 95.79M | 204.95M | 149.26M | 384.05M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -69.24M | -93.05M | -24.23M | -51.92M | -85.18M |
| Investing | -61k | -90k | -30k | -71k | -377k |
| Financing | 63.66M | 325.39M | 794k | 1.12M | 2.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -6.68M | -21.5M | -44.6M | -67.16M | -93.05M |
| Investing | -13k | -43k | -130k | -124k | -90k |
| Financing | 21.63M | 101.2M | 143.67M | 8.65M | 325.39M |
| Market Cap | 858.08M |
| Price to Earnings Ratio | -8.51 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.19 |
| Price to Book Ratio | 2.24 |
| Dividend Yield | - |
| Shares Outstanding | 52.29M |
| Average Volume (1 week) | 36.1k |
| Average Volume (1 Month) | 45.18k |
| 52 Week Change | -42.01% |
| 52 Week High | 33.00 |
| 52 Week Low | 15.37 |
| Spread (Intraday) | 1.67 (9.45%) |
| Company Name | Pharvaris NV |
| Address |
emmy noetherweg 2 leiden, south holland 2333 BK |
| Website | https://www.pharvaris.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
